INTRODUCTION:
Lithium therapy is commonly used in bipolar disorder treatment. Alongside the increasing prevalence of goiter and hypothyroidism, the sustaining use of lithium therapy is associated with several metabolic disorders, such as hypercalcemia and hyperparathyroidism (HPT).
CASE REPORT:
A 64-year-old woman with history of bipolar disorder treated with lithium for several years was referred to our department for evaluation of recurrent hypercalcemia and asymptomatic multinodular goiter (MNG).
Euthyroid MNG (benign fine needle biopsy) and a lithiumassociated Hyperparathyroidism (blood calcium 10.6 mg/ dl (8,4-10.2); phosphorus 2,06 mg/dl (2,0-4,0) PTH 256pg/dl (15-60)) were diagnosed. SestaMIBI scan was negative. A bone mineral densitometry showed reduced T-score in forearm (-2.0).
As lithium therapy was essential and could not be discontinued, we started bisphosphonate therapy (alendronate 70mg/week) and conservative management with regular follow-up was planned.
After 1 year of follow-up she showed a severe deterioration of the HPT with increasing calcium levels 
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